{
    "clinical_study": {
        "@rank": "112775", 
        "arm_group": [
            {
                "arm_group_label": "Hyoscine bromide", 
                "arm_group_type": "Experimental", 
                "description": "20 mg of hyosine bromide diluted in 100 ml of physiological serum (0.9% NaCl)."
            }, 
            {
                "arm_group_label": "Physiological serum", 
                "arm_group_type": "Placebo Comparator", 
                "description": "100 ml of physiological serum (0.9% NaCl)."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether hyoscine bromide decreases the duration of\n      the active phase of labor."
        }, 
        "brief_title": "Role of Hyoscine Bromide in Latent and Active Labor", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Labor, First Stage", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 18 or more.\n\n          -  Term pregnancy.\n\n          -  Cephalic presentation.\n\n          -  Oxytocin perfusion not present at the time of inclusion.\n\n          -  Uterine dynamic established.\n\n          -  Abscence of high risk factors or very high risk factors for pregnancy.\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Induction of labor.\n\n          -  Presence of risk factors.\n\n          -  Patients with hypersensitivity to the active substance or to any of the excipients or\n             any contraindication reflected in technical report."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103166", 
            "org_study_id": "2013-001921-19"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hyoscine bromide", 
                "description": "20 mg of hyosine bromide diluted in 100 ml of physiological serum (0.9% NaCl).", 
                "intervention_name": "Hyoscine bromide", 
                "intervention_type": "Drug", 
                "other_name": "Buscapina"
            }, 
            {
                "arm_group_label": "Physiological serum", 
                "description": "100 ml of physiological serum (0.9% NaCl).", 
                "intervention_name": "Physiological serum", 
                "intervention_type": "Drug", 
                "other_name": "Saline serum"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bromides", 
                "Scopolamine", 
                "Butylscopolammonium Bromide"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "contact": {
                "email": "mpalacio@clinic.ub.es", 
                "last_name": "Montse Palacio, PhD", 
                "phone": "932279946"
            }, 
            "facility": {
                "address": {
                    "city": "Barcelona", 
                    "country": "Spain", 
                    "zip": "08036"
                }, 
                "name": "Hospital Cl\u00ednic"
            }, 
            "investigator": {
                "last_name": "Montse Palacio, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Masked, Placebo-controlled Clinical Trial to Evaluate the Effects of a Single Intravenous Dose of Hyoscine Bromide on the Duration and Pain in Latent and Active Labor", 
        "overall_contact": {
            "email": "mpalacio@clinic.ub.es", 
            "last_name": "Montse Palacio, PhD", 
            "phone": "93 2279946"
        }, 
        "overall_official": [
            {
                "affiliation": "Hospital Cl\u00ednic de Barcelona", 
                "last_name": "Montse Palacio, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Cl\u00ednic de Barcelona", 
                "last_name": "Mariona Rius, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital Cl\u00ednic de Barcelona", 
                "last_name": "Ana Sandra Hernandez, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital Cl\u00ednic de Barcelona", 
                "last_name": "Irene Teixido, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital Cl\u00ednic de Barcelona", 
                "last_name": "Irene Vives, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Hospital Cl\u00ednic", 
                "last_name": "Midwives Collaborative Group HCP", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Time to complete dilation", 
            "safety_issue": "No", 
            "time_frame": "One hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103166"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hospital Clinic of Barcelona", 
            "investigator_full_name": "Montse Palacio", 
            "investigator_title": "MD, PhD.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hospital Clinic of Barcelona", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital Clinic of Barcelona", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}